Sugi Predict

Sugi Predict / Compounds / SCHEMBL8043325

SCHEMBL8043325

SCHEMBL8043325

C=C(/N=C/c1ccc(F)c(F)c1)O[Si](C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G7 Q13093 2/20 0.41
▸ MAPT P10636 4/20 0.37
▸ NFE2L2 Q16236 2/20 0.37
▸ TRPA1 O75762 1/20 0.35
▸ NPC1 O15118 5/20 0.35
▸ RAB9A P51151 3/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ SMN1; SMN2 Q16637 4/20 0.35
▸ KMT2A Q03164 3/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ AMY1A P0DUB6 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ PLEC Q15149 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ GAA P10253 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ NFKB2 Q00653 1/20 0.33
▸ RELA Q04206 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13929182 0.87 MAOA (0.37) PLA2G7AMY1A
SCHEMBL2800925 0.83 GRIN2D (0.39) PLA2G7MAPTNFE2L2TRPA1NPC1
SCHEMBL2800922 0.83 GRIN2D (0.39) PLA2G7MAPTNFE2L2TRPA1NPC1
SCHEMBL7839970 0.81 NPC1 (0.49) MAPTNFE2L2NPC1RAB9AMAPK1
SCHEMBL13928893 0.80 MAOB (0.40) MAPTTRPA1MAPK1KMT2AALDH1A1
SCHEMBL7840021 0.78 NFE2L2 (0.36) MAPTNFE2L2RAB9AGRIN1GRIN2B
SCHEMBL4220935 0.78 CHRM5 (0.49) MAPTNPC1RAB9AMAPK1SMN1; SMN2
SCHEMBL7842958 0.78 CHRM5 (0.49) MAPTNPC1RAB9AMAPK1SMN1; SMN2
SCHEMBL13092326 0.77 ALDH1A1 (0.30) MAPTALDH1A1
SCHEMBL7839894 0.77 HPGD (0.35) MAPTKMT2AALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7495007-B2 Spiroindolinone derivatives HOFFMANN-LA ROCHE INC. (US) 2009-02-24 — — US disclosed
US-7495007-B2 Spiroindolinone derivatives HOFFMANN-LA ROCHE INC. (US) 2009-02-24 — — US disclosed
US-20080188506-A1 SPIROINDOLINONE DERIVATIVES DING QINGJIE 2008-08-07 — — US disclosed
US-20080009486-A1 SPIROINDOLINONE DERIVATIVES HOFFMANN-LA ROCHE INC. 2008-01-10 — — US disclosed
US-20080009486-A1 SPIROINDOLINONE DERIVATIVES HOFFMANN-LA ROCHE INC. 2008-01-10 — — US disclosed
WO-2007104664-A1 SPIROINDOLINONE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-09-20 — — WO disclosed
US-20070213341-A1 Spiroindolinone derivatives CHEN LI 2007-09-13 — — US disclosed
US-20070213341-A1 Spiroindolinone derivatives CHEN LI 2007-09-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080009486-A1 SPIROINDOLINONE DERIVATIVES RB1, PKD1, KRAS PLA2G7 3148/4885MAPT 4581/4885NFE2L2 374/4885
US-20080188506-A1 SPIROINDOLINONE DERIVATIVES MKI67, MCL1, BAD PLA2G7 3181/4885MAPT 4092/4885NFE2L2 81/4885
US-20070213341-A1 Spiroindolinone derivatives MKI67, PKD1, RCC2 PLA2G7 3240/4885MAPT 4139/4885NFE2L2 83/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.